A phase Ib/II study of olutasidenib in patients with relapsed/refractory IDH1 mu
- This topic has 0 replies, 1 voice, and was last updated 4 years, 2 months ago by .
Viewing 1 post (of 1 total)
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.